EORTC-20021-LYMG

Gem-(R)CHOP versus (R)CHOP : a randomized Phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's Lymphoma
Trial StatusAll trial activities ended
DatesDate of activation: 26-Jan-04
Closed on : 23-Mar-07
Data management at EORTCFull
Phase2
Randomized trialYes
TypeHemato-malign
Targeted Sample size84
Number of steps1
DrugCyclophosphamide
Doxorubicin
Gemcitabine
Prednisone
Rituximab
Vincristine
Study Staff
Type of cancerNon Hodgkins Lymphoma
Participating GroupsEORTC Lymphoma Group(Coordinating Group)
Protocol summaryCancer.gov (PDQ)
ClinicalTrials.gov
NCT numberNCT00079261
EudraCT
Protocol documents in PDF
(requires password)
Study documentation
@
Back to Protocol section